小細胞肺がん治療の世界市場（～2026年）

• 英文タイトル：Global Small Cell Lung Cancer Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04652
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は小細胞肺がん治療のグローバル市場について調査・分析したレポートです。種類別（小細胞がん、混合型小細胞がん）市場規模、用途別（手術、放射線療法、化学療法）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別小細胞肺がん治療の競争状況、市場シェア
・世界の小細胞肺がん治療市場：種類別市場規模 2015年-2020年（小細胞がん、混合型小細胞がん）
・世界の小細胞肺がん治療市場：種類別市場規模予測 2021年-2026年（小細胞がん、混合型小細胞がん）
・世界の小細胞肺がん治療市場：用途別市場規模 2015年-2020年（手術、放射線療法、化学療法）
・世界の小細胞肺がん治療市場：用途別市場規模予測 2021年-2026年（手術、放射線療法、化学療法）
・北米の小細胞肺がん治療市場分析：米国、カナダ
・ヨーロッパの小細胞肺がん治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの小細胞肺がん治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の小細胞肺がん治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの小細胞肺がん治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Teva、Bristol myers、Novartis、Elekta、Siemens、Bedford、App pharmaceuticals
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market
The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Small Cell Lung Cancer Treatment Scope and Market Size
Small Cell Lung Cancer Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Small Cell Lung Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Teva
Bristol myers
Novartis
Elekta
Siemens
Bedford
App pharmaceuticals
…

Market segment by Type, the product can be split into
Oat Cancer
Combiner Small Cell Cancer
Market segment by Application, split into
Surgery
Radiation Therapy
Chemotherapy

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Small Cell Lung Cancer Treatment Revenue
1.4 Market by Type
1.4.1 Global Small Cell Lung Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oat Cancer
1.4.3 Combiner Small Cell Cancer
1.5 Market by Application
1.5.1 Global Small Cell Lung Cancer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Surgery
1.5.3 Radiation Therapy
1.5.4 Chemotherapy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Small Cell Lung Cancer Treatment Market Perspective (2015-2026)
2.2 Global Small Cell Lung Cancer Treatment Growth Trends by Regions
2.2.1 Small Cell Lung Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Small Cell Lung Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Small Cell Lung Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Small Cell Lung Cancer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Small Cell Lung Cancer Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Small Cell Lung Cancer Treatment Players by Market Size
3.1.1 Global Top Small Cell Lung Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Small Cell Lung Cancer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Small Cell Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Small Cell Lung Cancer Treatment Market Concentration Ratio
3.2.1 Global Small Cell Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Small Cell Lung Cancer Treatment Revenue in 2019
3.3 Small Cell Lung Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Small Cell Lung Cancer Treatment Product Solution and Service
3.5 Date of Enter into Small Cell Lung Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Small Cell Lung Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Small Cell Lung Cancer Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Small Cell Lung Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Small Cell Lung Cancer Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Small Cell Lung Cancer Treatment Market Size (2015-2020)
6.2 Small Cell Lung Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Small Cell Lung Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Small Cell Lung Cancer Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Small Cell Lung Cancer Treatment Market Size (2015-2020)
7.2 Small Cell Lung Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Small Cell Lung Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Small Cell Lung Cancer Treatment Market Size by Application (2015-2020)

8 China
8.1 China Small Cell Lung Cancer Treatment Market Size (2015-2020)
8.2 Small Cell Lung Cancer Treatment Key Players in China (2019-2020)
8.3 China Small Cell Lung Cancer Treatment Market Size by Type (2015-2020)
8.4 China Small Cell Lung Cancer Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Small Cell Lung Cancer Treatment Market Size (2015-2020)
9.2 Small Cell Lung Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan Small Cell Lung Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan Small Cell Lung Cancer Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Small Cell Lung Cancer Treatment Market Size (2015-2020)
10.2 Small Cell Lung Cancer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Small Cell Lung Cancer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Small Cell Lung Cancer Treatment Market Size by Application (2015-2020)

11 India
11.1 India Small Cell Lung Cancer Treatment Market Size (2015-2020)
11.2 Small Cell Lung Cancer Treatment Key Players in India (2019-2020)
11.3 India Small Cell Lung Cancer Treatment Market Size by Type (2015-2020)
11.4 India Small Cell Lung Cancer Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Small Cell Lung Cancer Treatment Market Size (2015-2020)
12.2 Small Cell Lung Cancer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Small Cell Lung Cancer Treatment Market Size by Type (2015-2020)
12.4 Central & South America Small Cell Lung Cancer Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Teva
13.1.1 Teva Company Details
13.1.2 Teva Business Overview
13.1.3 Teva Small Cell Lung Cancer Treatment Introduction
13.1.4 Teva Revenue in Small Cell Lung Cancer Treatment Business (2015-2020))
13.1.5 Teva Recent Development
13.2 Bristol myers
13.2.1 Bristol myers Company Details
13.2.2 Bristol myers Business Overview
13.2.3 Bristol myers Small Cell Lung Cancer Treatment Introduction
13.2.4 Bristol myers Revenue in Small Cell Lung Cancer Treatment Business (2015-2020)
13.2.5 Bristol myers Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Small Cell Lung Cancer Treatment Introduction
13.3.4 Novartis Revenue in Small Cell Lung Cancer Treatment Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Elekta
13.4.1 Elekta Company Details
13.4.2 Elekta Business Overview
13.4.3 Elekta Small Cell Lung Cancer Treatment Introduction
13.4.4 Elekta Revenue in Small Cell Lung Cancer Treatment Business (2015-2020)
13.4.5 Elekta Recent Development
13.5 Siemens
13.5.1 Siemens Company Details
13.5.2 Siemens Business Overview
13.5.3 Siemens Small Cell Lung Cancer Treatment Introduction
13.5.4 Siemens Revenue in Small Cell Lung Cancer Treatment Business (2015-2020)
13.5.5 Siemens Recent Development
13.6 Bedford
13.6.1 Bedford Company Details
13.6.2 Bedford Business Overview
13.6.3 Bedford Small Cell Lung Cancer Treatment Introduction
13.6.4 Bedford Revenue in Small Cell Lung Cancer Treatment Business (2015-2020)
13.6.5 Bedford Recent Development
13.7 App pharmaceuticals
13.7.1 App pharmaceuticals Company Details
13.7.2 App pharmaceuticals Business Overview
13.7.3 App pharmaceuticals Small Cell Lung Cancer Treatment Introduction
13.7.4 App pharmaceuticals Revenue in Small Cell Lung Cancer Treatment Business (2015-2020)
13.7.5 App pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Small Cell Lung Cancer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Small Cell Lung Cancer Treatment Revenue
Table 3. Ranking of Global Top Small Cell Lung Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Small Cell Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oat Cancer
Table 6. Key Players of Combiner Small Cell Cancer
Table 7. Global Small Cell Lung Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Small Cell Lung Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Small Cell Lung Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Small Cell Lung Cancer Treatment Market Share by Regions (2015-2020)
Table 11. Global Small Cell Lung Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Small Cell Lung Cancer Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Small Cell Lung Cancer Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Small Cell Lung Cancer Treatment Players
Table 18. Global Small Cell Lung Cancer Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Small Cell Lung Cancer Treatment Market Share by Players (2015-2020)
Table 20. Global Top Small Cell Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Cell Lung Cancer Treatment as of 2019)
Table 21. Global Small Cell Lung Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Small Cell Lung Cancer Treatment Product Solution and Service
Table 24. Date of Enter into Small Cell Lung Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Small Cell Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Small Cell Lung Cancer Treatment Market Size Share by Type (2015-2020)
Table 28. Global Small Cell Lung Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Small Cell Lung Cancer Treatment Market Size Share by Application (2015-2020)
Table 30. Global Small Cell Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Small Cell Lung Cancer Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Small Cell Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Small Cell Lung Cancer Treatment Market Share (2019-2020)
Table 34. North America Small Cell Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Small Cell Lung Cancer Treatment Market Share by Type (2015-2020)
Table 36. North America Small Cell Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Small Cell Lung Cancer Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Small Cell Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Small Cell Lung Cancer Treatment Market Share (2019-2020)
Table 40. Europe Small Cell Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Small Cell Lung Cancer Treatment Market Share by Type (2015-2020)
Table 42. Europe Small Cell Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Small Cell Lung Cancer Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Small Cell Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Small Cell Lung Cancer Treatment Market Share (2019-2020)
Table 46. China Small Cell Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Small Cell Lung Cancer Treatment Market Share by Type (2015-2020)
Table 48. China Small Cell Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Small Cell Lung Cancer Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Small Cell Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Small Cell Lung Cancer Treatment Market Share (2019-2020)
Table 52. Japan Small Cell Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Small Cell Lung Cancer Treatment Market Share by Type (2015-2020)
Table 54. Japan Small Cell Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Small Cell Lung Cancer Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Small Cell Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Small Cell Lung Cancer Treatment Market Share (2019-2020)
Table 58. Southeast Asia Small Cell Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Small Cell Lung Cancer Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Small Cell Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Small Cell Lung Cancer Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Small Cell Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Small Cell Lung Cancer Treatment Market Share (2019-2020)
Table 64. India Small Cell Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Small Cell Lung Cancer Treatment Market Share by Type (2015-2020)
Table 66. India Small Cell Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Small Cell Lung Cancer Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Small Cell Lung Cancer Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Small Cell Lung Cancer Treatment Market Share (2019-2020)
Table 70. Central & South America Small Cell Lung Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Small Cell Lung Cancer Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Small Cell Lung Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Small Cell Lung Cancer Treatment Market Share by Application (2015-2020)
Table 74. Teva Company Details
Table 75. Teva Business Overview
Table 76. Teva Product
Table 77. Teva Revenue in Small Cell Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 78. Teva Recent Development
Table 79. Bristol myers Company Details
Table 80. Bristol myers Business Overview
Table 81. Bristol myers Product
Table 82. Bristol myers Revenue in Small Cell Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 83. Bristol myers Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Small Cell Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Elekta Company Details
Table 90. Elekta Business Overview
Table 91. Elekta Product
Table 92. Elekta Revenue in Small Cell Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 93. Elekta Recent Development
Table 94. Siemens Company Details
Table 95. Siemens Business Overview
Table 96. Siemens Product
Table 97. Siemens Revenue in Small Cell Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 98. Siemens Recent Development
Table 99. Bedford Company Details
Table 100. Bedford Business Overview
Table 101. Bedford Product
Table 102. Bedford Revenue in Small Cell Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 103. Bedford Recent Development
Table 104. App pharmaceuticals Company Details
Table 105. App pharmaceuticals Business Overview
Table 106. App pharmaceuticals Product
Table 107. App pharmaceuticals Revenue in Small Cell Lung Cancer Treatment Business (2015-2020) (Million US$)
Table 108. App pharmaceuticals Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Cell Lung Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oat Cancer Features
Figure 3. Combiner Small Cell Cancer Features
Figure 4. Global Small Cell Lung Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 5. Surgery Case Studies
Figure 6. Radiation Therapy Case Studies
Figure 7. Chemotherapy Case Studies
Figure 8. Small Cell Lung Cancer Treatment Report Years Considered
Figure 9. Global Small Cell Lung Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Small Cell Lung Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Small Cell Lung Cancer Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Small Cell Lung Cancer Treatment Market Share by Players in 2019
Figure 14. Global Top Small Cell Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Cell Lung Cancer Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Small Cell Lung Cancer Treatment Revenue in 2019
Figure 16. North America Small Cell Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Small Cell Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Small Cell Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Small Cell Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Small Cell Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Small Cell Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Small Cell Lung Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介

非小細胞肺がん治療薬の世界市場（～2026年）

Global Non-small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04010 2020年11月20日 97Pages
当調査資料は非小細胞肺がん治療薬のグローバル市場について調査・分析したレポートです。種類別（Alimta、Iressa、Avastin、Tarceva、Zykadia、Tagrisso、Xalkori、Cyramza、Opdivo、Alecensa）市場規模、用途別（病院、クリニック）市場規模、地域...

小細胞肺がん治療薬の世界市場（～2026年）

Global Small Cell Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY04651 2020年11月20日 133Pages
当調査資料は小細胞肺がん治療薬のグローバル市場について調査・分析したレポートです。種類別（生物製剤、小分子）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、...

肺がん診断・治療の世界市場（～2026年）

Global Lung Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12547 2020年11月25日 128Pages
当調査資料は肺がん診断・治療のグローバル市場について調査・分析したレポートです。種類別（非小細胞肺がん、小細胞肺がん）市場規模、用途別（病院、がん研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

肺がん治療薬の世界市場（～2026年）

Global Lung Cancer Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12552 2020年11月25日 96Pages
当調査資料は肺がん治療薬のグローバル市場について調査・分析したレポートです。種類別（化学療法、標的療法、薬物、手術、放射線療法）市場規模、用途別（早期・中期肺がん治療、進行性肺がん治療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

肺癌の世界市場（～2026年）

Global Lung Cancer Market Size, Status and Forecast 2020-2026
MRC2-11QY12551 2020年11月25日 92Pages
当調査資料は肺癌のグローバル市場について調査・分析したレポートです。種類別（手術、化学療法、放射線療法、光線力学療法、レーザー療法）市場規模、用途別（病院・クリニック、がん研究センター、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

肺がんリキッドバイオプシーの世界市場（～2026年）

Global Lung Cancer Liquid Biopsy Market Size, Status and Forecast 2020-2026
MRC2-11QY12550 2020年11月25日 91Pages
当調査資料は肺がんリキッドバイオプシーのグローバル市場について調査・分析したレポートです。種類別（CTC、CtDNA、エクソソーム・RNA、その他）市場規模、用途別（クリニック、病院、診療所研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア...

スモールセルネットワークの世界市場（～2026年）

Global Small Cell Networks Market Size, Status and Forecast 2020-2026
MRC2-11QY04653 2020年11月20日 93Pages
当調査資料はスモールセルネットワークのグローバル市場について調査・分析したレポートです。種類別（フェムトセル、ピコセル、マイクロセル、メトロセル）市場規模、用途別（政府、小売、教育、エネルギー・電力、金融、医療、ホスピタリティ、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラン...

希少性肺疾患治療の世界市場（～2026年）

Global Orphan Lung Diseases Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04097 2020年11月20日 96Pages
当調査資料は希少性肺疾患治療のグローバル市場について調査・分析したレポートです。種類別（免疫抑制剤、抗炎症薬、抗線維化剤、血管拡張剤、コルチコステロイド、CFTRモジュレーター、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フ...

がん幹細胞治療の世界市場（～2026年）

Global Cancer Stem Cell Therapy Market Size, Status and Forecast 2020-2026
MRC2-11QY11233 2020年11月25日 92Pages
当調査資料はがん幹細胞治療のグローバル市場について調査・分析したレポートです。種類別（自家幹細胞移植、同種幹細胞移植、同系幹細胞移植、その他）市場規模、用途別（病院、クリニック、医学研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

肺がん診断検査の世界市場（～2026年）

Global Lung Cancer Diagnostic Tests Market Size, Status and Forecast 2020-2026
MRC2-11QY12548 2020年11月25日 94Pages
当調査資料は肺がん診断検査のグローバル市場について調査・分析したレポートです。種類別（イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他診断方法）市場規模、用途別（精密医療、個別化医療、がんモニタリング）市場規模、地域別（北米、米...

非小細胞肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Non-small Cell Lung Cancer Therapeutics Market The global Non-small Cell Lung Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Non-small Cell Lung Cancer Therapeu…
小細胞肺がん治療薬の世界市場（～2026年） Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…
肺がん診断・治療の世界市場（～2026年） Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the …
肺がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Therapeutics Market The global Lung Cancer Therapeutics market size is projected to reach US$ 15800 million by 2026, from US$ 14180 million in 2020, at a CAGR of 10.6%% during 2021-2026. Global Lung Cancer Therapeutics Scope and Market Size Lung Cance…
がん幹細胞治療の世界市場（～2026年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Stem Cell Therapy Scope and Market Size Cancer Stem Cell T…